Laser and energy-based device company, Lutronic Corporation, has introduced the Pico+4 laser device and the enCurve radiofrequency system to its portfolio.
The Pico+4 is a Nd:YAG laser device that offers both picosecond and nanosecond modes with four wavelengths, including 1064nm, 532nm, 595nm and 660nm.
CEO of Lutronic, Haelyung Hwang, said, “In developing this picosecond device, we wanted to ensure it would deliver improved fluence ranges, along with traditional gentle fluences, for expanded treatment options. “Our focus was to deliver the performance needed while maintaining the safety and efficacy physicians have grown to expect from Lutronic devices.”
As well as the Pico+4, Lutronic also announced the release of enCurve, an apoptosis-inducing radiofrequency system that targets adipocytes. The non-invasive device uses a frequency of 27.12MHz to heat adipocytes to cause denaturation of cells, leading to the death of the targeted adipocytes. It employs features such as Personalised Impedance Synchronisation Application (PISA), which is a cool tech feature that aims to ensure that the maximum amount of energy is delivered consistently into the fat cells. In real-time it will measure the amount of resistance the radiofrequency energy is running into when entering the body. Air Mode is also featured within the device, which aims to keep the skin perspiration free for added safety.
The two devices were announced at the Lutronic exhibition stand at the Aesthetics & Anti-aging Medicine World Congress in Monaco on March 31. According to the company, the devices will be available to practitioners in the UK when they have officially obtained their CE marks; the enCurve will be accredited in May and the Pico+4 later in the year.